跳至主要内容
临床试验/JPRN-UMIN000051093
JPRN-UMIN000051093招募中Unknown

Optimization of preoperative chemotherapy for breast cancer using whole genome sequencing -prediction of pathological complete response and exploration of a novel target for patients with non-pathological complete response- - Breast Cancer Whole Genome Sequencing Study

West Japan Oncology Group0 个研究点目标入组 240 人开始时间: 2023年5月18日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients with a history of invasive malignancy within the past 3 years from the time consent was obtained. 2. Have an active infection requiring systemic treatment. 3. Have poorly controlled diabetes mellitus or hypertension. 4. Patients with unstable angina, myocardial infarction within 6 months, or clinically significant arrhythmia requiring treatment. 5. Congestive heart failure, poorly controlled valvular heart disease, dilated cardiomyopathy, or hypertrophic cardiomyopathy consistent with New York Heart Association (NYHA) Classification II or higher. 6. Receiving continuous systemic administration of steroids " exceeding 10mg/day of prednisolone equivalent"or immunosuppressive agents. 7. Other cases deemed inappropriate by the physician in charge.

研究者

相似试验